Patents by Inventor Helene Catherine Eugenie Rudyk

Helene Catherine Eugenie Rudyk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds useful for inhibiting ROR-gamma-t
    Patent number: 10603320
    Abstract: The present invention provides novel ROR gamma-t inhibitors and pharmaceutical compositions thereof. Formula (I).
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: March 31, 2020
    Assignee: Eli Lilly and Company
    Inventors: Charles Willis Lugar, III, John Richard Morphy, Timothy Ivo Richardson, Helene Catherine Eugenie Rudyk, Selma Sapmaz, Ryan Edward Stites
  • COMPOUNDS USEFUL FOR INHIBITING ROR-GAMMA-T
    Publication number: 20200009139
    Abstract: The present invention provides novel ROR gamma-t inhibitors and pharmaceutical compositions thereof. Formula (I).
    Type: Application
    Filed: February 27, 2018
    Publication date: January 9, 2020
    Inventors: Charles Willis Lugar, III, John Richard Morphy, Timothy Ivo Richardson, Helene Catherine Eugenie Rudyk, Selma Sapmaz, Ryan Edward Stites
  • Morpholine derivatives as norepinephrine reuptake inhibitors
    Patent number: 7423037
    Abstract: Compounds of the general formula (I) are inhibitors of the reuptake of norepinephrine. As such, they may be useful for the treatment of disorders of the central and/or peripheral nervous system.
    Type: Grant
    Filed: October 28, 2004
    Date of Patent: September 9, 2008
    Assignee: Eli Lilly and Company
    Inventors: Gordon Iain Campbell, Manuel Javier Cases-Thomas, Teresa Man, John Joseph Masters, Hélène Catherine Eugénie Rudyk, Magnus Wilhelm Walter
  • 2-(phenoxymethyl)-and 2-(phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors
    Patent number: 7384941
    Abstract: Compounds of formula (I): wherein A is S or O; R is H; Ar is an optionally substituted phenyl group; X is an optionally substituted phenyl group, a C1-C4 alkyl, a C3-C6 cycloalkyl group or a CH2(C3-C6 cycloalkyl) group; R? is H or C1-C4 alkyl; and each R1 is independently H or C1-C4 alkyl; and pharmaceutically acceptable salts thereof are selective inhibitors of norepinephrine reuptake.
    Type: Grant
    Filed: August 18, 2003
    Date of Patent: June 10, 2008
    Assignee: Eli Lilly and Company
    Inventors: Magnus Wilhelm Walter, Barry Peter Clark, Peter Thaddeus Gallagher, Helen Louise Haughton, Hélène Catherine Eugénie Rudyk
  • Aryl and heteroaryl morpholine derivatives
    Patent number: 7354920
    Abstract: Compounds of formula (I) wherein Rx is H; Ry is H or C1-C4 alkyl; each Rz is independently H or C1-C4 alkyl; X represents O; Y represents OH or OR; R is C1-C4 alkyl; and Ar1 and Ar2 are optionally substituted phenyl or 5- or 6-membered heteroaryl rings are selective inhibitors of the reuptake of norepinephrine.
    Type: Grant
    Filed: August 18, 2003
    Date of Patent: April 8, 2008
    Assignee: Eli Lilly and Company
    Inventors: Manuel Javier Cases-Thomas, Helen Louise Haughton, Robin George Simmonds, Hélène Catherine Eugénie Rudyk, Magnus Wilhelm Walter, Sivi Ouwerkerk-Mahadevan, John Joseph Masters, Carlos Lamas-Peteira